Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	230.16	457.41	647.25	739.66	372.47	325.12
Trading Asset Securities	50	-	-	-	-	250
Cash & Short-Term Investments	280.16	457.41	647.25	739.66	372.47	575.12
Cash Growth	-52.16%	-29.33%	-12.49%	98.58%	-35.24%	0.27%
Accounts Receivable	188.39	205.32	156	133.02	126.66	142.17
Other Receivables	1.4	9.38	13.94	16.87	1.36	3.44
Receivables	189.79	214.7	169.94	149.9	128.02	145.62
Inventory	275.78	264.38	271.83	208.23	195.31	193.04
Prepaid Expenses	-	-	-	-	0.69	0.31
Other Current Assets	31.89	14.46	16.13	31.08	15.45	15.12
Total Current Assets	777.62	950.95	1,105	1,129	711.95	929.21
Property, Plant & Equipment	710.42	721.4	656.49	648.01	601.68	554.23
Long-Term Investments	13.5	13.5	13.5	13.5	-	-
Goodwill	517.6	517.6	529.23	542.4	542.4	565.45
Other Intangible Assets	135.53	138.63	151.24	153.87	156.75	139.89
Long-Term Deferred Tax Assets	23.9	21.85	18.4	18.81	17.18	18.27
Long-Term Deferred Charges	21.17	17.41	13.45	11.48	15.6	34.73
Other Long-Term Assets	22.17	19.54	25.18	28.67	20.65	14.34
Total Assets	2,222	2,401	2,513	2,546	2,066	2,256
Accounts Payable	69.66	44.83	83	76.29	52.35	57.24
Accrued Expenses	8	19.37	32.5	30.42	20.09	14.35
Short-Term Debt	260	516.09	306	633.68	377	770.12
Current Portion of Long-Term Debt	-	-	-	213.5	-	-
Current Income Taxes Payable	13.43	0.72	13.65	4.86	8.59	4.48
Current Unearned Revenue	26.76	11.05	24.26	130.69	31.06	26.12
Other Current Liabilities	6.56	3.96	6.36	19.81	7.25	5.92
Total Current Liabilities	384.4	596.02	465.77	1,109	496.34	878.22
Long-Term Debt	-	-	-	-	285.18	272.12
Long-Term Unearned Revenue	19.75	20.57	20.77	18.51	11.72	11.68
Long-Term Deferred Tax Liabilities	19.28	19.36	15.42	14.71	11.27	13.66
Total Liabilities	423.43	635.94	501.95	1,142	804.51	1,176
Common Stock	512.53	512.21	364.69	229.18	221.64	203.52
Additional Paid-In Capital	845.81	844.13	982	575.92	460.91	292.5
Retained Earnings	527.37	495.8	657.68	553.51	519.38	524.79
Treasury Stock	-93.95	-93.86	-	-	-	-
Comprehensive Income & Other	6.72	6.65	6.31	44.53	59.75	59.63
Shareholders' Equity	1,798	1,765	2,011	1,403	1,262	1,080
Total Liabilities & Equity	2,222	2,401	2,513	2,546	2,066	2,256
Total Debt	260	516.09	306	847.18	662.18	1,042
Net Cash (Debt)	20.16	-58.68	341.25	-107.52	-289.71	-467.12
Net Cash Per Share	0.04	-0.11	0.74	-0.25	-0.72	-1.20
Filing Date Shares Outstanding	526.12	500.58	510.56	449.27	434.42	398.89
Total Common Shares Outstanding	526.12	499.49	510.56	449.19	434.42	398.89
Working Capital	393.21	354.93	639.39	19.62	215.61	51
Book Value Per Share	3.42	3.53	3.94	3.12	2.90	2.71
Tangible Book Value	1,145	1,109	1,330	706.87	562.55	375.09
Tangible Book Value Per Share	2.18	2.22	2.61	1.57	1.29	0.94
Buildings	-	527.78	542.22	412.29	419.33	428.15
Machinery	-	418.7	329.97	259.01	254.01	252.67
Construction In Progress	-	157.88	131.95	280.88	198.46	118.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.